Glaxo Wellcome UK Ltd is recalling four batches of Respontin Nebules due to results of impurities during a routine stability testing.
The batches are being recalled because of specification results for impurities being found during a routine stability testing. As far as the company is aware, there have been no adverse reactions from taking the drugs that have been reported.
But we all know how serious such small problems with medicines and medical products can be. Our Group Action Lawyers have been fighting for the rights of medical group cases for years, so know all too well how bad things can get…
Recalling stock
Any remaining stock of the four affected batches should be quarantined and returned to the original supplier. The products are being discontinued so no alternative batches will be available.
Those that receive the Drug Alert should bring it to the attention of any relevant person. It is the responsibility of NHS regional teams to inform the relevant clinics, general practitioners, and community pharmacies.
For returns and credit enquires, you should contact your local AAH branch or Alliance Healthcare.
For any medical enquires you should contact GlaxoSmithKline UK Medical Information Department. Click for more information on the recall!
Making a claim
At the Group Action Lawyers, we specialise in group actions claims and have been dealing with high profile medical group actions like the PIP Breast Implant Scandal; Metal-On-Metal Hip Implant problems; and the Daybrook Dental Action, to name a few.
If you think you have a claim we urge you to contact us. If we think you have a claim we can get you the compensation that you deserve.